Company intelligence / Profile preview

Ennov

United States

Ownership: Private
Development stage: Other

Overview

Ennov is a leading global provider of unified, AI-powered compliance and process management platforms for pharmaceutical, biotech, medical device, CRO, and animal health companies, supporting clinical, regulatory, safety (pharmacovigilance), and quality workflows at scale.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

industry collaborations with CROs, pharmaceutical companies, and regulatory authorities

Beyond the preview

Go deeper on Ennov.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ennov.

Explore the full profile